News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Distribution Of Circular To Adcock Ingram Shareholders In Respect Of A Scheme Of Arrangement And Posting Of CFR Pharmaceuticals Combined Prospectus And Pre-Listing Statement


11/20/2013 8:50:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTIAGO, Chile, Nov. 19, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription medicines, today announced that the circular ("Circular") containing details of the scheme of arrangement ("Scheme") and incorporating notices of meetings of Adcock Ingram shareholders, forms of proxy and an election, surrender and transfer form and CFR's combined prospectus and pre-listing statement ("Prospectus"), has been distributed to Adcock Ingram shareholders. An announcement ("Announcement") of the distribution of the Circular and the Prospectus was made on the Stock Exchange News Service operated by the JSE Limited on November 18, 2013. Also, a supplement to the Circular will be distributed to Adcock Ingram shareholders as soon as is reasonably possible stating that the Takeover Regulation Panel has requested that certain holders of a separate class of shares may not vote those shares at one of the shareholder meetings to approve the Scheme and that a certain letter of support from a shareholder in relation to the Scheme has to lie open for inspection.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES